• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[非特异性及心脏选择性β受体阻滞剂对房水生成的影响。眼压测量研究]

[Effect of nonspecific and cardioselective beta receptor blockers on the formation of aqueous humor. An oculopressure tonometry study].

作者信息

Pillunat L E, Stodtmeister R

机构信息

Universitäts-Augenklinik, Ulm, BRD.

出版信息

Ophthalmologica. 1988;196(2):67-75. doi: 10.1159/000309878.

DOI:10.1159/000309878
PMID:3283632
Abstract

The aim of the present study was to show the effect of different topical beta-blocking agents on aqueous humor formation with a clinically practicable method. In a clinical, randomized, prospective double-blind study, 60 healthy volunteers were examined by means of oculopression tonometry according to Ulrich. The placebo was applied to 29 subjects; a nonselective beta-blocker (timolol maleate 0.5%) was given to 14 volunteers and 17 subjects received a cardioselective, beta-1-blocking agent (betaxolol-HCl 0.5%). On the 1st day, intraocular pressure (IOP) was lowered by the suction cup method and then we measured the time required for IOP to return to the initial value. The examination procedure of the 1st day was repeated on the 2nd day 3 h after application of the ophthalmic solution. After evaluation of the different groups, we could show that the recovery times in the placebo groups were comparable. Furthermore, we showed that both beta-blockers slow down the increase of IOP to the initial value. There was a statistically significant difference in recovery time between timolol and placebo. This difference was statistically not significant between betaxolol and placebo.

摘要

本研究的目的是用一种临床可行的方法来展示不同局部β受体阻滞剂对房水生成的影响。在一项临床随机前瞻性双盲研究中,60名健康志愿者按照乌尔里希眼压测量法接受了眼压迫眼压测量检查。29名受试者使用了安慰剂;14名志愿者使用了非选择性β受体阻滞剂(0.5%马来酸噻吗洛尔),17名受试者使用了心脏选择性β1受体阻滞剂(0.5%盐酸倍他洛尔)。在第一天,通过吸盘法降低眼内压(IOP),然后我们测量IOP恢复到初始值所需的时间。在第二天,在应用眼药水3小时后重复第一天的检查程序。在对不同组进行评估后,我们发现安慰剂组的恢复时间相当。此外,我们还发现两种β受体阻滞剂都减缓了IOP回升到初始值的速度。噻吗洛尔和安慰剂之间的恢复时间存在统计学上的显著差异。倍他洛尔和安慰剂之间的这种差异在统计学上不显著。

相似文献

1
[Effect of nonspecific and cardioselective beta receptor blockers on the formation of aqueous humor. An oculopressure tonometry study].[非特异性及心脏选择性β受体阻滞剂对房水生成的影响。眼压测量研究]
Ophthalmologica. 1988;196(2):67-75. doi: 10.1159/000309878.
2
Comparison of ophthalmic beta-blocking agents.眼科β受体阻滞剂的比较。
Clin Pharm. 1987 Jun;6(6):451-63.
3
The effect of betaxolol and timolol on postoperative intraocular pressure.
Acta Ophthalmol (Copenh). 1993 Aug;71(4):458-62. doi: 10.1111/j.1755-3768.1993.tb04618.x.
4
Betaxolol vs timolol. A six-month double-blind comparison.
Arch Ophthalmol. 1986 Jan;104(1):46-8. doi: 10.1001/archopht.1986.01050130056019.
5
Changing therapy from timolol to betaxolol. Effect on intraocular pressure in selected patients with glaucoma. Timolol-Betaxolol Study Group.
Arch Ophthalmol. 1989 Sep;107(9):1303-7. doi: 10.1001/archopht.1989.01070020373038.
6
Betaxolol hydrochloride ophthalmic suspension 0.25% and timolol gel-forming solution 0.25% and 0.5% in pediatric glaucoma: a randomized clinical trial.盐酸倍他洛尔眼用混悬液0.25%与噻吗洛尔凝胶形成溶液0.25%和0.5%用于儿童青光眼:一项随机临床试验。
J AAPOS. 2009 Aug;13(4):384-90. doi: 10.1016/j.jaapos.2009.04.017.
7
Betaxolol and timolol. A comparison of efficacy and side effects.倍他洛尔与噻吗洛尔。疗效及副作用比较。
Arch Ophthalmol. 1984 Jan;102(1):42-5. doi: 10.1001/archopht.1984.01040030026028.
8
[Aqueous humor flow measured by fluorophotometry. A comparative study of the effect of various beta-blocker eyedrops in patients with ocular hypertension].[通过荧光光度法测量房水流量。不同β受体阻滞剂滴眼液对高眼压症患者影响的比较研究]
Ophtalmologie. 1990 Mar-Apr;4(2):156-61.
9
Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.青光眼治疗中的眼部β受体阻滞剂。临床药理学方面。
Drugs Aging. 1992 May-Jun;2(3):208-21. doi: 10.2165/00002512-199202030-00005.
10
Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma.
Arch Ophthalmol. 1977 Apr;95(4):601-4. doi: 10.1001/archopht.1977.04450040067008.